Last mentioned: Mar 24, 2026
SCOTUS Mifepristone Hearing
Supreme Court hears arguments regarding the FDA's regulation of medication abortion pills.
National Data Release
Reports confirm U.S. abortion numbers held steady despite 14 state-level bans.
Shield Law Expansion
States like MA and NY implement laws protecting providers from out-of-state legal actions.
Dobbs Decision
U.S. Supreme Court overturns Roe v. Wade, returning abortion regulation to the states.
Despite the implementation of near-total bans in 14 states, the national volume of abortions in the U.S. has remained steady or increased. This resilience is driven by a surge in medication abortion, the expansion of telehealth, and the emergence of state 'shield laws' that protect providers across jurisdictional lines.
This page surfaces every story mentioning U.S. Food and Drug Administration (FDA) across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where U.S. Food and Drug Administration (FDA) was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |